Molecular-genetic substantiation of combined therapy in the early postoperative period in diffuse peritonitis
https://doi.org/10.24884/0042-4625-2021-180-6-43-48
Abstract
The OBJECTIVE was to give a molecular genetic foundation of combination therapy in the early postoperative period for peritonitis.
METHODS AND MATERIALS. 70 patients with diffuse peritonitis were studied: the first (n=35) – patients underwent basic treatment, the second (n=35) – combined treatment with the inclusion of Remaxol and laser irradiation. The severity of endotoxemia and oxidative stress, the state of the hemostasis system and the functional status of the liver were determined. Molecular genotyping of the following genes was performed: beta subunits of platelet fibrinogen receptor (T1565C, ITGB3), fibrinogen (G(-455)A, FGB), catalase (-262C/T, CAT), superoxide dismutase (C47T, SOD2).
RESULTS. It was found that the early postoperative period in patients with peritonitis is accompanied by endotoxemia, oxidative stress, impaired functional status of the liver, hypercoagulation and hypofibrinolysis. In patients with conditionally «mutant» genotypes of the studied genes, peritonitis is more severe, the severity of changes in the studied indicators of homeostasis is greater. At the same time, the effectiveness of therapy decreased, the number of complications increased, and the stay of patients in the hospital increased. The early inclusion of Remaxol and laser radiation in basic therapy increases the overall effectiveness of treatment: the severity of endotoxemia and oxidative stress decreases, the functional state of the liver and hemostasis system is restored relatively quickly, and as a result, an improvement in clinical results has been registered (a 37.5 % decrease in the frequency of complications (χ2=3.360, p=0.047) and a reduction in the length of stay of patients in the hospital by 16.6 % (p<0.05)).
CONCLUSION. The inclusion of Remaxol and laser therapy in the early postoperative period in the treatment regimen of patients with peritonitis makes it possible to influence pathogenetically important links of the disease relatively quickly, which improves treatment results. This type of therapy is particularly effective in patients with polymorphic genotypes T1565C and C1565C of the ITGB3 gene.
About the Authors
A. P. VlasovRussian Federation
Vlasov Alexey P. - Head of the Department of Faculty Surgery.
68, str. Bolshevitskaya, Saransk, 430005
Competing Interests:
The authors declare no conflict of interest
Sh. S. Al-Kubaisi
Russian Federation
Al-Kubiysi Sheikh-Ahmed S. - Associate Professor of the Department of Faculty Surgery.
Saransk
Competing Interests:
The authors declare no conflict of interest
T. I. Vlasova
Russian Federation
Vlasova Tatiana I. - Head of the Department of Normal and Pathological Physiology.
Saransk
Competing Interests:
The authors declare no conflict of interest
Y. K. Salakhov
Russian Federation
Salakhov Yeriken K. - Applicant of the Department of Faculty Surgery.
Saransk
Competing Interests:
The authors declare no conflict of interest
N. A. Myshkina
Russian Federation
Myshkina Nina A. - Assistant of the Department of Hospital Therapy.
Saransk
Competing Interests:
The authors declare no conflict of interest
D. A. Romanov
Russian Federation
Romanov Denis A. - Applicant of the Department of Faculty Surgery.
Saransk
Competing Interests:
The authors declare no conflict of interest
F. A. Ali-Fuad
Russian Federation
Ali-Fuad Farid A. - Postgraduate Student of the Department of Faculty Surgery.
Saransk
Competing Interests:
The authors declare no conflict of interest
S. T. Al-Anbari
Russian Federation
Al-Anbari Saif T. - Postgraduate Student of the Department of Faculty Surgery.
Saransk
Competing Interests:
The authors declare no conflict of interest
References
1. Dzebisov A. D. Modern approaches to the diagnosis and treatment of peritonitis // Colloquium-magazine. 2019;15(39(3)):18–20. (In Russ.).
2. Vinnik Y. S., Yakimov S. V. Tuhtaeva N. M. Yakimov I. S. The possibilities of application of gaseous ozone in treatment of diffuse peritonitis. Bulletin of physiotherapy and balneology. 2019; 25(3):87–88. (In Russ.).
3. Korovin A. J., Bazlov S. B., Andreeva M. B., Narsiya V. V., Trifanov N. A. Manifistations of abdominal sepsis in patients with diffuse peritonitis // Kuban Scientific Medical Bulletin. 2017;(6): 78–83. (In Russ.). Doi: 10.25207/1608-6228-2017-24-6-78-83.
4. Burkova T. V., Goncharova I. A. Genetic factors affecting the effectiveness and safety of long-term anticoagulant therapy // Molecular Medicine. 2016;14(5):22–32. (In Russ.).
5. Yue B.Y. The role of genetics in medicine: a future of precision medicine // BCMJ. 2019;61(10): 388–389. https://bcmj.org/articles/role-geneticsmedicine-future-precision-medicine).
6. Myshkina N. A., Vlasova T. I., Leshchankina N. Yu., Vlasov P. A., Radaikina O. G., Polozova E. I., Spirina M. A. The effectiveness of quantum metabolic therapy in increasing the tolerance of the heart to oxidative-toxic damage // Modern problems of science and education. 2015;(2):2. (In Russ.). Available at: http://www.science-education.ru/ru/article/view?id=23161 (accessed: 18.01.2022).
7. Kantsaliev L. B., Teuvov A. A., Baziev A. M., Soltanov E. I., Tlupova L. M. Complex treatment of acute widespread peritonitis using ozone therapy and laser blood irradiation // Kuban Scientific Medical Bulletin. 2012;(2):100–104. (In Russ.).
8. Orlov Yu. P., Lukach V. N., Govorova N. V., Glushchenko A. V., Dmitriva O. D. The place of Remaxol as a hepatoprotector and antioxidant in the intensive care of generalized peritonitis // Anesthesiology and resuscitation. 2015;(6):24–29. (In Russ.).
Supplementary files
Review
For citations:
Vlasov A.P., Al-Kubaisi Sh.S., Vlasova T.I., Salakhov Y.K., Myshkina N.A., Romanov D.A., Ali-Fuad F.A., Al-Anbari S.T. Molecular-genetic substantiation of combined therapy in the early postoperative period in diffuse peritonitis. Grekov's Bulletin of Surgery. 2021;180(6):43-48. (In Russ.) https://doi.org/10.24884/0042-4625-2021-180-6-43-48